| Year |
Citation |
Score |
| 2022 |
Lindner K, Beckenbauer K, van Ek LC, Titeca K, de Leeuw SM, Awwad K, Hanke F, Korepanova AV, Rybin V, van der Kam EL, Mohler EG, Tackenberg C, Lakics V, Gavin AC. Isoform- and cell-state-specific lipidation of ApoE in astrocytes. Cell Reports. 38: 110435. PMID 35235798 DOI: 10.1016/j.celrep.2022.110435 |
0.639 |
|
| 2020 |
Krishnan N, Chen X, Donnelly-Roberts D, Mohler EG, Holtzman DM, Gopalakrishnan SM. Small Molecule Phenotypic Screen Identifies Novel Regulators of LDLR Expression. Acs Chemical Biology. PMID 33270420 DOI: 10.1021/acschembio.0c00851 |
0.301 |
|
| 2020 |
Gardner RS, Newman LA, Mohler EG, Tunur T, Gold PE, Korol DL. Aging is not equal across memory systems. Neurobiology of Learning and Memory. 172: 107232. PMID 32315762 DOI: 10.1016/J.Nlm.2020.107232 |
0.668 |
|
| 2019 |
Petros AM, Korepanova A, Jakob CG, Qui W, Panchal SC, Wang J, Dietrich J, Brewer J, Pohlki F, Kling A, Wilcox K, Lakics V, Bahnassawy L, Reinhardt P, Karunan Partha S, ... ... Mohler E, et al. Fragment-based Discovery of an ApolipoproteinE4 (apoE4) Stabilizer. Journal of Medicinal Chemistry. PMID 30933499 DOI: 10.1021/acs.jmedchem.9b00178 |
0.242 |
|
| 2018 |
Ding Z, Brown JW, Rueter LE, Mohler EG. Profiling attention and cognition enhancing drugs in a rat touchscreen-based continuous performance test. Psychopharmacology. PMID 29332255 DOI: 10.1007/s00213-017-4827-y |
0.297 |
|
| 2017 |
Hudzik TJ, Basso AM, Lynch JJ, Bracken WM, Mohler EG, Kohlhaas KL, Xu H, Haig G, Gault L. Preclinical abuse liability assessment of ABT-126, an agonist at the α7 nicotinic acetylcholine receptor (nAChR). Pharmacology, Biochemistry, and Behavior. PMID 28579351 DOI: 10.1016/J.Pbb.2017.05.010 |
0.447 |
|
| 2015 |
Mohler EG, Ding Z, Rueter LE, Chapin D, Young D, Kozak R. Cross-site strain comparison of pharmacological deficits in the touchscreen visual discrimination test. Psychopharmacology. PMID 26177580 DOI: 10.1007/s00213-015-4012-0 |
0.363 |
|
| 2014 |
Mohler EG, Franklin SR, Rueter LE. Discriminative-stimulus effects of NS9283, a nicotinic α4β2* positive allosteric modulator, in nicotine-discriminating rats. Psychopharmacology. 231: 67-74. PMID 23925734 DOI: 10.1007/s00213-013-3207-5 |
0.366 |
|
| 2012 |
Mohler EG, Baker PM, Gannon KS, Jones SS, Shacham S, Sweeney JA, Ragozzino ME. The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats. Psychopharmacology. 220: 687-96. PMID 21989804 DOI: 10.1007/S00213-011-2518-7 |
0.723 |
|
| 2012 |
Lenz RA, Baker JD, Locke C, Rueter LE, Mohler EG, Wesnes K, Abi-Saab W, Saltarelli MD. The scopolamine model as a pharmacodynamic marker in early drug development. Psychopharmacology. 220: 97-107. PMID 21901320 DOI: 10.1007/S00213-011-2456-4 |
0.47 |
|
| 2011 |
Webster SJ, Wilson CA, Lee CH, Mohler EG, Terry AV, Buccafusco JJ. The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys. British Journal of Pharmacology. 164: 970-8. PMID 21486290 DOI: 10.1111/J.1476-5381.2011.01432.X |
0.381 |
|
| 2011 |
Mohler EG, Browman KE, Roderwald VA, Cronin EA, Markosyan S, Scott Bitner R, Strakhova MI, Drescher KU, Hornberger W, Rohde JJ, Brune ME, Jacobson PB, Rueter LE. Acute inhibition of 11beta-hydroxysteroid dehydrogenase type-1 improves memory in rodent models of cognition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 5406-13. PMID 21471376 DOI: 10.1523/Jneurosci.4046-10.2011 |
0.505 |
|
| 2011 |
Kohlhaas KL, Robb H, Roderwald V, Markosyan S, Salte K, Bitner RS, Mohler E, Terry AV, Buccafusco J, Rueter LE, Lee L, Gopalakrishnan M. α7 NNR allosteric modulation in behavioral models of cognition Biochemical Pharmacology. 82: 1042. DOI: 10.1016/J.Bcp.2011.07.050 |
0.398 |
|
| 2010 |
Radek RJ, Kohlhaas KL, Rueter LE, Mohler EG. Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists. Current Pharmaceutical Design. 16: 309-22. PMID 20109141 DOI: 10.2174/138161210790170166 |
0.457 |
|
| 2010 |
Mohler EG, Franklin SR, Rueter LE, Fox GB, Decker MW, Browman KE. ABT-594 improves performance in the 5-choice serial reaction time task under conditions of increased difficulty, sub-chronic dosing, and in poorly-performing subjects. Pharmacology, Biochemistry, and Behavior. 95: 146-57. PMID 20064548 DOI: 10.1016/J.Pbb.2009.12.019 |
0.465 |
|
| 2010 |
Morris KA, Chang Q, Mohler EG, Gold PE. Age-related memory impairments due to reduced blood glucose responses to epinephrine. Neurobiology of Aging. 31: 2136-45. PMID 19178987 DOI: 10.1016/J.Neurobiolaging.2008.12.003 |
0.691 |
|
| 2010 |
Mohler E, Browman KE, Roderwald VA, Cronin EA, Strakhova MI, Markosyan S, Bitner RS, Drescher K, Rohde JJ, Brune ME, Jacobson PB, Rueter LE. P3-302: Cognitive effects of 11beta-hydroxysteroid dehydrogenase1 inhibitors are accompanied by changes in CREB phosphorylation and glucocorticoid inhibition Alzheimer's & Dementia. 6: S540-S540. DOI: 10.1016/J.Jalz.2010.05.1803 |
0.382 |
|
| 2010 |
Gaalen MMV, Barghorn S, Bitner RS, Ebert U, Behl B, Meyer A, Mohler E, Gross G, Jacobson P. 11β HSD-1 inhibition reduces Aβ pathology in a mouse model of Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1802 |
0.337 |
|
| 2009 |
Ragozzino ME, Mohler EG, Prior M, Palencia CA, Rozman S. Acetylcholine activity in selective striatal regions supports behavioral flexibility. Neurobiology of Learning and Memory. 91: 13-22. PMID 18845266 DOI: 10.1016/J.Nlm.2008.09.008 |
0.629 |
|
| 2009 |
Franklin S, Mohler E, Komater V, Robb H, Radek R, Rustay N, Brown J, Gopalakrishnan M, Decker M, Rueter L. Positive allosteric modulation of α4β2 nicotinic receptors potentiates some CNS effects of the α4β2 agonist, ABT-594 Biochemical Pharmacology. 78: 921. DOI: 10.1016/J.Bcp.2009.06.083 |
0.429 |
|
| 2007 |
Mohler EG, Shacham S, Noiman S, Lezoualc'h F, Robert S, Gastineau M, Rutkowski J, Marantz Y, Dumuis A, Bockaert J, Gold PE, Ragozzino ME. VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux. Neuropharmacology. 53: 563-73. PMID 17692343 DOI: 10.1016/J.Neuropharm.2007.06.016 |
0.707 |
|
| 2006 |
Roderwald VA, Robb HM, Kaye KT, Brown JW, Zhu CZ, Nikkel AL, Dellovade TL, Mohler EG. P1-133: PROFILING THE TGF344AD TRANSGENIC RAT MODEL OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P323-P323. DOI: 10.1016/j.jalz.2018.06.136 |
0.275 |
|
| 2006 |
Shacham S, Milgram B, Araujo J, Ragazzino M, Mohler E, Marantz Y, Mercedes L, Noiman S. O3-05-03 Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.225 |
0.276 |
|
| 1999 |
Williams JM, Mohler EG, Givens B. The role of the medial prefrontal cortex in attention: Altering predictability of task difficulty Psychobiology. 27: 462-469. |
0.597 |
|
| Show low-probability matches. |